A Chakrabarti
Overview
Explore the profile of A Chakrabarti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
303
Citations
4128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Biswal M, Gupta P, Kanaujia R, Kaur K, Kaur H, Vyas A, et al.
J Hosp Infect
. 2022 Feb;
122:173-179.
PMID: 35124141
Background: An unprecedented rise in the number of COVID-19-associated mucormycosis (CAM) cases has been reported in India. Myriad hypotheses are proposed for the outbreak. We recently reported uncontrolled diabetes and...
2.
Chakrabarti M, Dutta S, Chattapadhyay S, Sarkar A, Sanyal D, Chakrabarti A
Nanotechnology
. 2021 Dec;
15(12).
PMID: 34911206
Nanocrystalline BiOhas been prepared by a ball milling process. The particle size of the ball-milled BiOpowder has been determined by the x-ray powder diffraction method and transmission electron microscopy. The...
3.
Fernandes G, Spiers A, Vaidya N, Zhang Y, Sharma E, Holla B, et al.
BMC Public Health
. 2021 Oct;
21(1):1920.
PMID: 34686158
Background: Adverse childhood experiences (ACEs) increases vulnerability to externalising disorders such as substance misuse. The study aims to determine the prevalence of ACEs and its association with substance misuse. Methods:...
4.
Banerjee S, Majors R, Luchian E, Chakrabarti A
QJM
. 2021 Jan;
114(5):324-325.
PMID: 33486524
No abstract available.
5.
Patel A, Kaur H, Xess I, Michael J, Savio J, Rudramurthy S, et al.
Clin Microbiol Infect
. 2019 Dec;
26(7):944.e9-944.e15.
PMID: 31811914
Objectives: To describe the epidemiology, management and outcome of individuals with mucormycosis; and to evaluate the risk factors associated with mortality. Methods: We conducted a prospective observational study involving consecutive...
6.
Dubey N, Capoor M, Hasan A, Gupta A, Ramesh V, Sharma S, et al.
Epidemiol Infect
. 2019 Oct;
147:e294.
PMID: 31637988
Mycetoma is a chronic granulomatous, suppurative and progressive inflammatory disease that usually involves the subcutaneous tissue and bones after traumatic inoculation of the causative organism. In India, actinomycotic mycetoma is...
7.
Draper C, Duisters K, Weger B, Chakrabarti A, Harms A, Brennan L, et al.
Sci Rep
. 2019 Apr;
9(1):5797.
PMID: 30940838
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
8.
Sehgal I, Dhooria S, Choudhary H, Aggarwal A, Garg M, Chakrabarti A, et al.
Clin Microbiol Infect
. 2019 Jan;
25(9):1157.e1-1157.e7.
PMID: 30685498
Objectives: The treatment response in chronic pulmonary aspergillosis (CPA) is usually assessed based on the improvement in clinical and imaging findings. Herein, we evaluate serum Aspergillus fumigatus-specific IgG, serum galactomannan,...
9.
Draper C, Duisters K, Weger B, Chakrabarti A, Harms A, Brennan L, et al.
Sci Rep
. 2018 Oct;
8(1):14568.
PMID: 30275458
The menstrual cycle is an essential life rhythm governed by interacting levels of progesterone, estradiol, follicular stimulating, and luteinizing hormones. To study metabolic changes, biofluids were collected at four timepoints...
10.
Honnavar P, Ghosh A, Paul S, Shankarnarayan S, Singh P, Dogra S, et al.
Diagn Microbiol Infect Dis
. 2018 Jul;
92(2):118-123.
PMID: 30025965
The taxonomy of Malassezia species is evolving with introduction of molecular techniques, and difficulty is faced to identify the species by phenotypic methods. Among 15 known Malassezia species, the present...